Cargando…
Human papillomavirus (HPV) vaccine coverage achievements in low and middle-income countries 2007–2016
INTRODUCTION: Since 2007, HPV vaccine has been available to low and middle income countries (LAMIC) for small-scale ‘demonstration projects’, or national programmes. We analysed coverage achieved in HPV vaccine demonstration projects and national programmes that had completed at least 6 months of im...
Autores principales: | Gallagher, Katherine E., Howard, Natasha, Kabakama, Severin, Mounier-Jack, Sandra, Burchett, Helen E.D., LaMontagne, D. Scott, Watson-Jones, Deborah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710977/ https://www.ncbi.nlm.nih.gov/pubmed/29179873 http://dx.doi.org/10.1016/j.pvr.2017.09.001 |
Ejemplares similares
-
What works for human papillomavirus vaccine introduction in low and middle-income countries?
por: Howard, Natasha, et al.
Publicado: (2017) -
Lessons learnt from human papillomavirus (HPV) vaccination in 45 low- and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2017) -
Social mobilisation, consent and acceptability: a review of human papillomavirus vaccination procedures in low and middle-income countries
por: Kabakama, Severin, et al.
Publicado: (2016) -
The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countries
por: Howard, N., et al.
Publicado: (2016) -
Vaccine programme stakeholder perspectives on a hypothetical single-dose human papillomavirus (HPV) vaccine schedule in low and middle-income countries
por: Gallagher, Katherine E., et al.
Publicado: (2018)